Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share

Statistics for the 2023 & 2024 Non-steroidal Anti-Inflammatory Drugs (NSAIDs) market share, created by Mordor Intelligence™ Industry Reports. Non-steroidal Anti-Inflammatory Drugs (NSAIDs) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Anti-inflammatory Research NSAIDs Drugs Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Industry

The NSAIDs market is moderately competitive, with several players across the globe. In terms of market share, few of the major players currently dominate the market. With the increase in research and development activity, many regional players are expected to contribute to the NSAIDs market over the forecast period. Some of the key players in the market are Pfizer Inc., GlaxoSmithKline Plc, Johnson and Johnson, Bayer AG, Sanofi S.A., Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd, Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Assertio Therapeutics, Inc., and others.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Leaders

  1. Pfizer Inc.

  2. Johnson & Johnson

  3. Bayer AG

  4. Sanofi S.A.

  5. GlaxoSmithKline plc

*Disclaimer: Major Players sorted in no particular order

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration

NSAIDs Market Report Snapshots

Non-Steroidal Anti-Inflammatory Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)